Showing results (81-90 of 97) with videos related to
Sort By:
Pageof 10
Scandinavian Journal of Immunology|September 3, 2011
The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times dailyD Torfoss, B Sandstad, T E Mollnes, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimensS Smeland, A K Blystad, S O Kvaløy, et al.Breast Cancer Research and Treatment|September 20, 2001
Effects of dose-intensive chemotherapy and radiotherapy on serum n-terminal proatrial natriuretic peptide in high-risk breast cancer patientsK S Hall, T Wiklund, B Erikstein, et al.Blood|May 1, 1991
T-cell receptor tau delta +/CD3+4-8-T- cell acute lymphoblastic leukemias: a distinct subgroup of leukemias in children. A report of five casesG C Alfsen, K Beiske, H Holte, et al.International Journal of Cancer|August 24, 2000
Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphomaT Stokke, E Galteland, H Holte, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2011
Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosisA Fosså, I H Fiskvik, A Kolstad, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma GroupJ W Sweetenham, G Santini, W Qian, et al.Bone Marrow Transplantation|November 13, 2001
Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelinesT Nordøy, A Husebekk, I S Aaberge, et al.Journal of the American Medical Informatics Association : JAMIA|July 3, 2010
Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients' need for symptom management support: a randomized clinical trialCornelia M Ruland, Harald H Holte, Jo Røislien, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 2007
Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-upM Björkholm, H Hagberg, H Holte, et al.Pageof 10